Type-2 innate lymphoid cells control the development of atherosclerosis in mice

Type-2 innate lymphoid cells (ILC2) affect adipose tissue metabolism and function. Here the authors show that the ILC2 are present in para-aortic adipose tissue and represent a major source of IL-5 and IL-13 required for mounting atheroprotective immunity, which can be altered by high fat diet.

Guardado en:
Detalles Bibliográficos
Autores principales: Stephen A. Newland, Sarajo Mohanta, Marc Clément, Soraya Taleb, Jennifer A. Walker, Meritxell Nus, Andrew P. Sage, Changjun Yin, Desheng Hu, Lauren L. Kitt, Alison J. Finigan, Hans-Reimer Rodewald, Christoph J. Binder, Andrew N. J. McKenzie, Andreas J. Habenicht, Ziad Mallat
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Q
Acceso en línea:https://doaj.org/article/40b5f6eeef3343c8899a0bd9503d2198
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:40b5f6eeef3343c8899a0bd9503d2198
record_format dspace
spelling oai:doaj.org-article:40b5f6eeef3343c8899a0bd9503d21982021-12-02T15:37:04ZType-2 innate lymphoid cells control the development of atherosclerosis in mice10.1038/ncomms157812041-1723https://doaj.org/article/40b5f6eeef3343c8899a0bd9503d21982017-06-01T00:00:00Zhttps://doi.org/10.1038/ncomms15781https://doaj.org/toc/2041-1723Type-2 innate lymphoid cells (ILC2) affect adipose tissue metabolism and function. Here the authors show that the ILC2 are present in para-aortic adipose tissue and represent a major source of IL-5 and IL-13 required for mounting atheroprotective immunity, which can be altered by high fat diet.Stephen A. NewlandSarajo MohantaMarc ClémentSoraya TalebJennifer A. WalkerMeritxell NusAndrew P. SageChangjun YinDesheng HuLauren L. KittAlison J. FiniganHans-Reimer RodewaldChristoph J. BinderAndrew N. J. McKenzieAndreas J. HabenichtZiad MallatNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-11 (2017)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Stephen A. Newland
Sarajo Mohanta
Marc Clément
Soraya Taleb
Jennifer A. Walker
Meritxell Nus
Andrew P. Sage
Changjun Yin
Desheng Hu
Lauren L. Kitt
Alison J. Finigan
Hans-Reimer Rodewald
Christoph J. Binder
Andrew N. J. McKenzie
Andreas J. Habenicht
Ziad Mallat
Type-2 innate lymphoid cells control the development of atherosclerosis in mice
description Type-2 innate lymphoid cells (ILC2) affect adipose tissue metabolism and function. Here the authors show that the ILC2 are present in para-aortic adipose tissue and represent a major source of IL-5 and IL-13 required for mounting atheroprotective immunity, which can be altered by high fat diet.
format article
author Stephen A. Newland
Sarajo Mohanta
Marc Clément
Soraya Taleb
Jennifer A. Walker
Meritxell Nus
Andrew P. Sage
Changjun Yin
Desheng Hu
Lauren L. Kitt
Alison J. Finigan
Hans-Reimer Rodewald
Christoph J. Binder
Andrew N. J. McKenzie
Andreas J. Habenicht
Ziad Mallat
author_facet Stephen A. Newland
Sarajo Mohanta
Marc Clément
Soraya Taleb
Jennifer A. Walker
Meritxell Nus
Andrew P. Sage
Changjun Yin
Desheng Hu
Lauren L. Kitt
Alison J. Finigan
Hans-Reimer Rodewald
Christoph J. Binder
Andrew N. J. McKenzie
Andreas J. Habenicht
Ziad Mallat
author_sort Stephen A. Newland
title Type-2 innate lymphoid cells control the development of atherosclerosis in mice
title_short Type-2 innate lymphoid cells control the development of atherosclerosis in mice
title_full Type-2 innate lymphoid cells control the development of atherosclerosis in mice
title_fullStr Type-2 innate lymphoid cells control the development of atherosclerosis in mice
title_full_unstemmed Type-2 innate lymphoid cells control the development of atherosclerosis in mice
title_sort type-2 innate lymphoid cells control the development of atherosclerosis in mice
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/40b5f6eeef3343c8899a0bd9503d2198
work_keys_str_mv AT stephenanewland type2innatelymphoidcellscontrolthedevelopmentofatherosclerosisinmice
AT sarajomohanta type2innatelymphoidcellscontrolthedevelopmentofatherosclerosisinmice
AT marcclement type2innatelymphoidcellscontrolthedevelopmentofatherosclerosisinmice
AT sorayataleb type2innatelymphoidcellscontrolthedevelopmentofatherosclerosisinmice
AT jenniferawalker type2innatelymphoidcellscontrolthedevelopmentofatherosclerosisinmice
AT meritxellnus type2innatelymphoidcellscontrolthedevelopmentofatherosclerosisinmice
AT andrewpsage type2innatelymphoidcellscontrolthedevelopmentofatherosclerosisinmice
AT changjunyin type2innatelymphoidcellscontrolthedevelopmentofatherosclerosisinmice
AT deshenghu type2innatelymphoidcellscontrolthedevelopmentofatherosclerosisinmice
AT laurenlkitt type2innatelymphoidcellscontrolthedevelopmentofatherosclerosisinmice
AT alisonjfinigan type2innatelymphoidcellscontrolthedevelopmentofatherosclerosisinmice
AT hansreimerrodewald type2innatelymphoidcellscontrolthedevelopmentofatherosclerosisinmice
AT christophjbinder type2innatelymphoidcellscontrolthedevelopmentofatherosclerosisinmice
AT andrewnjmckenzie type2innatelymphoidcellscontrolthedevelopmentofatherosclerosisinmice
AT andreasjhabenicht type2innatelymphoidcellscontrolthedevelopmentofatherosclerosisinmice
AT ziadmallat type2innatelymphoidcellscontrolthedevelopmentofatherosclerosisinmice
_version_ 1718386228049477632